C 23 H 16 ClN5O, monoclinic, P21/c (no. 14), a = 10.0503(6) Å, b = 17.5265(9) Å, c = 22.8763(16) Å, β = 91.554(6)°,
CCDC no.: 1896315
CrysAlis PRO [1] , SHELX [2, 3] , WinGX/ORTEP [4] The asymmetric unit of the title crystal structure containing two molecules is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters. 
Source of material
The title compound was synthesized from treatment of 2-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazole-3-carbonyl)-N-phenylhydrazinecarbothioamide with anhydrous sodium acetate in boiling ethanol for 5 h. The solid obtained on cooling the reaction mixture was filtered, washed with ethanol, dried and crystallized from dimethylformamide to give colorless crystals (63%) of the title compound, Mp. 238−240°C.
Experimental details
H atoms were positioned geometrically and refined using a riding model. U iso (H) for aromatic and N-H hydrogens were set to 1.2 times Ueq for the atoms they are bonded to. Aromatic C-H bonds were fixed at 0.93 Å and N-H at 0.86 Å. The weakly diffracting crystal yielded a wR2 factor slightly larger than 20%. Nevertheless the data weren't cut, as the strongest of them may provide some information.
Comment
Heterocycles containing the 1,3,4-oxadiazol-2-amine moiety show different biological activities and act as anticancer and antiproliferative agents [5] [6] [7] [8] . Also, the pyrazole ring system is the core of a number of drugs such as celecoxib, fezolamide and difenamizole [9] [10] [11] . The asymmetric unit comprises two independent molecules (see the figure) . The molecule consists of five rings: phenyl (R1), oxadiazolyl (R2), pyraxolyl (R3), chlorophenyl (R4) and a second phenyl (R5) ring linked to R3. The twist angles between the planes of pairs of linked rings R1-R2, R2-R3, R3-R4, R3-R5 are 17.54 (11) 
